Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2012; 18(48): 7149-7157
Published online Dec 28, 2012. doi: 10.3748/wjg.v18.i48.7149
Published online Dec 28, 2012. doi: 10.3748/wjg.v18.i48.7149
Pathway | Amino acid substitution in the rt domain | LAM | LdT | ETV | ADV | TDF |
WT | S | S | S | S | S | |
L-nucleoside (LAM/LdT) | M204I/V | R | R | I | S | S |
Acyclic phosphonate (ADV) | N236T | S | S | S | R | I |
Shared (LAM, LdT, ADV) | A181T/V | R | R | S | R | I |
Double(ADV, TDF) | A181T/V + N236T | R | R | S | R | R |
D-Cyclopentane (ETV) | L180M + M204V/I ± I169 ± T184 ± S202 ± M250 | R | R | R | S | S |
- Citation: Song ZL, Cui YJ, Zheng WP, Teng DH, Zheng H. Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues. World J Gastroenterol 2012; 18(48): 7149-7157
- URL: https://www.wjgnet.com/1007-9327/full/v18/i48/7149.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i48.7149